Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 148 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia				Phase III, Phase II				001-0015-211 NCT00127387
	Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer				Phase III				MDA-ID-00156 NCI-3410, 3410, NCT00024167
	Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases				Phase III				CALGB-90202 ECOG-CALGB-90202, NCT00079001, SWOG-CALGB-90202, CAN-NCIC-PRC2
	Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy				Phase III				SWOG-S0421 S0421, NCT00134056
	Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer				Phase III				05-043 NCT00116142
	Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma				Phase III				553 NCT00132301
	Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial				Phase III				05-8-4 NCT00243646
	Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer				Phase III				ECOG-E3805 E3805, NCT00309985
	Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer				Phase III				RTOG-0521 NCT00288080
	Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy				Phase III				RTOG-0518 0518, NCT00329797


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute